MingSight Pharmaceuticals
Organization
Trials
Phase 1/2, Terminated, 60 people, Apr 10, 2018
Named in competing interests
Clonal dynamics on the road to hematological malignancy (MBL, MGUS, CH)
Fees or honoraria, Aug 9, 2026
Sources: pubmed.ncbi.nlm.nih.gov